Market Value361,837,867
Total Holdings36
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BBIO / BridgeBio Pharma, Inc.
CYTK / Cytokinetics, Incorporated
OKUR / OnKure Therapeutics, Inc.
LIVN / LivaNova PLC
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ICLR / ICON Public Limited Company
SDGR / Schrödinger, Inc.
RNTX / Rein Therapeutics Inc.
FTRE / Fortrea Holdings Inc.
IMNM / Immunome, Inc.
SAVA / Cassava Sciences, Inc. Put
TECX / Tectonic Therapeutic, Inc.
OEF / iShares Trust - iShares S&P 100 ETF Put
VKTX / Viking Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
OVID / Ovid Therapeutics Inc.
COGT / Cogent Biosciences, Inc.
MCK / McKesson Corporation
IMRX / Immuneering Corporation
SHATTUCK LABS INC / PUT Call (82024L953)
DXCM / DexCom, Inc.
SEM / Select Medical Holdings Corporation
NBIX / Neurocrine Biosciences, Inc.
CRVL / CorVel Corporation Put
ACCD / Accolade, Inc.
ADCT / ADC Therapeutics SA
ZBH / Zimmer Biomet Holdings, Inc.
SYRE / Spyre Therapeutics, Inc.
CNC / Centene Corporation
ROIV / Roivant Sciences Ltd.
MURA / Mural Oncology plc
CRBP / Corbus Pharmaceuticals Holdings, Inc.
JANX / Janux Therapeutics, Inc.
ZYME / Zymeworks Inc.
ERAS / Erasca, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
MGTX / MeiraGTx Holdings plc
MRVI / Maravai LifeSciences Holdings, Inc.
ABCL / AbCellera Biologics Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ACHC / Acadia Healthcare Company, Inc.
FOLD / Amicus Therapeutics, Inc.
STTK / Shattuck Labs, Inc.
SGHT / Sight Sciences, Inc.
KURA / Kura Oncology, Inc.
IMVT / Immunovant, Inc.
CTMX / CytomX Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
PRTA / Prothena Corporation plc
BPMC / Blueprint Medicines Corporation
CDNA / CareDx, Inc
HAE / Haemonetics Corporation
GLPG / Galapagos NV - Depositary Receipt (Common Stock) Call